Health-related quality of life in patients with aggressive non-Hodgkin lymphoma: results from the PETAL trial.

Ann Hematol · 2025 · PMC12141138 · PMID 40397196

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Even within the same end-of-treatment response group, iPET-positive patients tended to report lower HRQoL than iPET-negative patients, but most of the differences failed to reach statistical significance (Table S12 ).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.